2025-07-30 2026-07-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 16617725 bus:FullAccounts 2025-07-30 2026-07-31 16617725 bus:Micro-entities 2025-07-30 2026-07-31 16617725 bus:AuditExempt-NoAccountantsReport 2025-07-30 2026-07-31 16617725 bus:SmallCompaniesRegimeForAccounts 2025-07-30 2026-07-31 16617725 bus:PrivateLimitedCompanyLtd 2025-07-30 2026-07-31 16617725 2025-07-30 2026-07-31 16617725 2026-07-31 16617725 bus:RegisteredOffice 2025-07-30 2026-07-31 16617725 core:WithinOneYear 2026-07-31 16617725 core:AfterOneYear 2026-07-31 16617725 2024-07-30 16617725 bus:Director1 2025-07-30 2026-07-31 16617725 bus:Director1 2026-07-31 16617725 bus:CompanySecretary1 2025-07-30 2026-07-31 16617725 bus:LeadAgentIfApplicable 2025-07-30 2026-07-31 16617725 2025-07-29 16617725 core:CostValuation core:Non-currentFinancialInstruments 2026-07-31 16617725 core:CostValuation core:Non-currentFinancialInstruments 2025-07-29 16617725 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-07-31 16617725 core:Non-currentFinancialInstruments 2026-07-31 16617725 core:Non-currentFinancialInstruments 2025-07-29 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16617725
England and Wales

 

 

 

RAWMEDLAW CYF.


Unaudited Financial Statements
 


Period of accounts

Start date : 30 July 2025

End date : 31 July 2026
 
 
 
£
2026
£
Current assets 6,510 
Creditors: amount falling due within one year (1,568)
Net current assets/(liabilities) 4,942 
Total assets less current liabilities 4,942 
Net assets/(liabilities) 4,942 
 
Capital and reserves 4,942 
 



Notes to the Accounts
Statutory Information
Rawmedlaw Cyf. is a private limited company, limited by shares, domiciled in England and Wales, registration number 16617725, registration address Greystone House Alexandra Place, Newbridge, Newport, NP11 4ES, Wales.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the period was 0.

Director's Responsibilities:
  1. For the period ended 31 July 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
Rebecca Alice Whiticar
Director

Date approved: 01 September 2026
1